Building the national drug policy on evidence - A cross sectional study on assessing implementation in Lao PDR

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 33, Issue 3, 2002, Pages 647-653

  Paphassarang, C ^a   Wahlstrom R ^b   Phoummalaysith, B ^a   Boupha, B ^b   Tomson, G ^b  

^a Ministry of Health   (Laos)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CASE CONTROL STUDY; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; EDUCATION; HEALTH CARE QUALITY; HUMAN; LAOS; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PHARMACY; PILOT STUDY; PRACTICE GUIDELINE; PUBLIC HEALTH; STANDARD;

CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EDUCATION, PHARMACY; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LAOS; NATIONAL HEALTH PROGRAMS; PHARMACEUTICAL SERVICES; PILOT PROJECTS; PROGRAM EVALUATION; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE;

EID: 0038826763     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Adiku MU, Osondu BO. Four years of essential drug list in Nigeria. Soc Sci Med 1991; 33: 1005-10.
2. Cederlof C, Tomson G. Private pharmacies and the health sector reform in developing countries. J Soc Admin Pharmacol 1995; 12: 101-12.
3. Boupha B, Phounsavath S, Phimmasone V, Tomson G, Wahlstrom R. Health Systems Research (HSR) for National Drug Policy Implementation, Final report on HSR training and reports from five project groups. Vientiane: Ministry of Health, Lao PDR, 2000.
4. Boupha B. National Health Survey 2000. Vientiane: Ministry of Health, Lao PDR, 2001.
5. Goel P, Ross-Degnan D, Berman P, Soumerai S. Retail pharmacies in developing countries: a behaviour and intervention framework. Soc Sci Med 1996; 42: 1155-61.
6. Hamrell S, Nordberg O, eds. Health and drug policies: Making them the top of the agenda. A strategy paper on the development of national drug policies. Develop Dialogue 1995; 1: 5-24.
7. Helling-Borda M, Andersson G. Lao National Drug Policy Programme. Stockholm: Sida Evaluation Report no. 00/9; 2000.
8. Hogerzeil HV, Walker GJ, Sallami AO, Fernando G. Impact of an essential drugs program on availability and rational use of drugs. Lancet 1989; 1: 141-2
9. Hogerzeil HV, Bimo, Ross-Degnan D, et al. Field tests for rational drug use in twelve developing countries. Lancet 1993; 342: 1408-10.
10. Johansson R, Suren G. Inspection Seminar: Quality of Drugs. National Drug Policy Programme, Lao PDR. Stockholm: Karolinska Institutet, IHCAR, Report 97/10; 1997.
11. Laing R, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001; 16: 13-20.
12. Le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM, Intervention research in rational use of drugs: a review. Health Policy Plan 1999; 14: 89-102.
13. Muir Gray JA. Evidence-based healthcare, how to make health policy and management decisions. Edinburgh: Churchill Livingstone, 1997.
14. National Statistics Center, State Planning Committee. Basic statistics about the socio-economic development in the Lao PDR, 1997. Vientiane: National Statistical Center, State Planning Committee, 1998.
15. Paphassarang C, Tomson G, Choprapawon C, Weerasuriya K. The Lao National Drug Policy: lessons along the journey. Lancet 1995; 345: 433-5.
16. Stenson B, Tomson G, Syhakhang L. Pharmaceutical regulation in context: the case of Lao PDR. Health Policy Plan 1997; 12: 329-40.
17. Stenson B, Lindgren BH, Syhakhang L, Tomson G. The quality of drugs in private pharmacies in Lao PDR. Int J Risk Safety Med 1998; 11: 243-9.
18. Stenson B, Syhakhang L, Eriksson B, Tomson G. Real world pharmacy: Assessing the quality of private pharmacy practice in the Lao People's Democratic Republic. Soc Sci Med 2001a; 52: 393-404.
19. Stenson B, Syhakhang L, Stalsby Lundborg C, Eriksson B, Tomson G. Private pharmacy prac-tice and regulation, a randomized trial in Lao PDR. Int J Health Techn Assessm Health Care 2001b; 17: 579-89.
20. Wolffers I. The role of pharmaceuticals in the privatisation process in Vietnam's health-care system. Soc Sci Med 1995; 41: 1325-32.
21. World Health Organization. Ethical Criteria for Medicinal Drug Promotion. Geneva: WHO, 1988.
22. World Health Organization. Action Program on Essential Drugs: Indicators for monitoring national drug policies, a practical manual. WHO/DAP/94.12, 1994.
23. World Health Organization. Action Program on Essential Drugs: Comparative analysis of national drug policies. WHO/DAP/97.6, 1997.
24. World Health Organization. Counterfeit and substandard drugs in Myanmar and Vietnam. WHO/ EDM/QSM/99-3, 1999.
25. World Health Organization. Medicines Strategy: 2000-20003. WHO/EDM/2000.1, 2000a.
26. World Health Organization. World Health Report 2000. Geneva: WHO, 2000b.